智通财经APP讯，天大药业(00455)发布公告，预期集团截至2024年12月31日止年度的公司股东应占亏损由2023年12月31日止年度的2420万港元增加至不少于6100万港元。公司股东应占亏损增加原因主要由于：(1)集团本财政年度收入较上一个年度下跌约38%;及(2)本财政年度计提130万港元的商誉减值准备(此减值是非经常性、非现金性质的，不会对集团的现金流量造成任何影响)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.